ArticleBMC endocrine disorders2026
Predicting permanent hypoparathyroidism after thyroidectomy: role of early postoperative parathyroid hormone levels and surgical factors.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to determine the incidence of permanent hypoparathyroidism (PH) after thyroidectomy and evaluate the association between PH and perioperative surgical, clinical, and biochemical factors.
methodsPatients who underwent total or completion thyroidectomy between 2017 and 2024 were retrospectively evaluated. PH was defined as a serum parathyroid hormone (PTH) level < 15 pg/mL and the need for active vitamin D, with or without calcium supplementation, to prevent hypocalcemic symptoms persisting for at least 6 months postoperatively. Patients were categorized according to PH status, and clinical, surgical, and biochemical parameters were analyzed.
resultsAmong the 498 eligible patients, 18 (3.6%) developed PH. A postoperative day 1 PTH level ≤ 7 pg/mL predicted PH with 86.7% sensitivity and 90.3% specificity and was an independent risk factor in multivariate analysis (odds ratio [OR]: 16.60, p < 0.001). Completion thyroidectomy was also independently associated with PH (OR: 6.14, p = 0.027). Postoperative day 1 calcium ≤ 8.3 mg/dL (OR: 14.20, p < 0.001) and the presence of parathyroid tissue in the surgical specimen (OR: 6.25, p < 0.001) were significant in univariate analysis but not in multivariate analysis (p = 0.08 and p = 0.056, respectively).
conclusionsPermanent hypoparathyroidism remains a clinically significant complication of thyroidectomy, with an incidence of 3.6% in our cohort. A postoperative day 1 PTH ≤ 7 pg/mL was independently associated with PH and demonstrated an excellent negative predictive value (99.4%), supporting its clinical utility for ruling out PH rather than confidently predicting it. Completion thyroidectomy was also independently associated with PH. Given the limited number of events, these findings warrant validation in larger, prospective cohorts. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.